Life Science Disruptors →
September 14th, 2016
Cambridge, MA-based C4 Therapeutics has named chief scientific officer Andrew Phillips its president. Phillips is taking over for former president and CEO Jason Fisherman, who has resigned to pursue other opportunities.
Ben Fidler is Xconomy's Deputy Biotechnology Editor. You can e-mail him at email@example.com Follow @benthefidler
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Early-stage startups compete for the title of Startup of the Year
Robust ecosystem supports tech hub and startup community
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.